USPTO Examiner DAHER KIRA B - Art Unit 3785

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18646639POWERED ANKLE EXOSKELETON WITH SERIES-ELASTIC ACTUATIONApril 2024July 2025Allow1420NoNo
17923438WEARABLE AIR PURIFIERNovember 2022February 2026Abandon3910NoNo
17938578PASSIVE EXOSKELETON FOR SIT-TO-STAND AND STAND-TO-SIT TRANSFEROctober 2022July 2025Allow3310NoNo
17953239RESPIRATION-ENHANCEMENT INSERT FOR A FACE MASK TO INCLUDE MEDICAL FACEMASKSeptember 2022March 2026Abandon4210NoNo
17810809RESPIRATORY MASK SEALING INTERFACEJuly 2022October 2025Abandon3920YesNo
17786947PASSIVE LOAD BALANCERJune 2022January 2026Abandon4310NoNo
17804605RE-USABLE ELASTOMERIC RESPIRATOR AND VENTILATOR WITH FILTER INSERTS AND PORTSMay 2022March 2026Abandon4610NoNo
17827731Creeping Motion Therapy DeviceMay 2022October 2025Allow4110YesNo
17776538LUMBAR RETRACTORMay 2022May 2025Allow3610YesNo
17775162DRY POWDER INHALER WITH AN ADHERENCE/COMPLIANCE MONITORMay 2022January 2026Allow4520YesNo
17712014BREATH-ACTUATED NEBULIZER FOR MEDICINE INHALATIONApril 2022November 2025Abandon4310NoNo
17701894MOTION ASSISTANCE APPARATUSMarch 2022March 2025Allow3600NoNo
17753583SUPPLEMENTARY GAS SOURCE DETECTION AND RELATED APPARATUSES AND METHODSMarch 2022January 2026Allow4720YesNo
17597267VENTILATOR AND METHOD FOR CONTROLLING A GAS SOURCE AND TWO ROTARY VALVESDecember 2021August 2025Allow4310YesNo
17622920INHALERDecember 2021September 2025Abandon4510NoNo
17621656SHOULDER REHABILITATION DEVICE AND METHODDecember 2021March 2025Abandon3820NoNo
17555187Flexor PressDecember 2021December 2024Allow3610YesNo
17552530SYSTEM, DEVICE AND METHOD FOR PROVIDING COMPRESSION THERAPY IN SYNCHRONIZATION WITH BREATHING CYCLEDecember 2021August 2025Abandon4410NoNo
17609491PORTABLE ROBOTISED APPARATUS WITH FUNCTIONAL ELECTROSTIMULATION FOR ASSISTED JOINT REHABILITATIONNovember 2021April 2025Abandon4110NoNo
17608806LENGTH ADJUSTMENT DEVICE FOR A FINGER MOTION RAIL, LENGTH-ADJUSTABLE FINGER MOTION RAIL, AND THERAPEUTIC DEVICE COMPRISING AT LEAST ONE LENGTH-ADJUSTABLE FINGER MOTION RAIL OF THIS TYPE, AND METHOD FOR LENGTH ADJUSTMENTNovember 2021September 2024Allow3510NoNo
17508955BIOFILM REMOVAL DEVICE FOR ENDOTRACHEAL TUBESOctober 2021December 2024Allow3810YesNo
17459923SYSTEM AND METHOD FOR A WEARABLE AIR FILTRATION DEVICESeptember 2021February 2025Abandon4110NoNo
17481216Systems And Methods For Multi Modal Personalized Topical Pain ReliefSeptember 2021July 2025Abandon4620NoNo
17437898NASAL MASKSeptember 2021February 2026Abandon5341NoNo
17437098SYSTEMS AND METHODS FOR CONTROLLING AN ORAL IRRIGATORSeptember 2021May 2025Allow4420NoNo
17466714RESPIRATOR MASK FILTER ADAPTERSeptember 2021September 2024Allow3700NoNo
17433628BREATHING ISOLATION MASK AND BREATHING ASSISTANCE SYSTEMAugust 2021July 2025Abandon4711NoNo
17397804Nocireceptor BlockadeAugust 2021September 2025Abandon5020NoNo
17391264NOSE BRIDGE STRIP WITH SCENT RELEASING MECHANISM AND MASK STRUCTURE HAVING THE SAMEAugust 2021March 2025Abandon4311NoNo
17381630DRUG DELIVERY CONTAINER AND NEBULIZER DEVICEJuly 2021April 2025Allow4520YesNo
17374026COMPRESSOR SYSTEMS FOR BAG VALVE MASKSJuly 2021November 2024Abandon4010NoNo
17374165TRANSPARENT MEDICAL FACEMASK COMPOSITE AND FACEMASKS FORMED THEREBYJuly 2021September 2025Allow5020NoYes
17370710Wearable Continuous Positive Airway Pressure AssemblyJuly 2021April 2024Allow3300NoNo
17419498RESPIRATORY MASK AND VENTILATION THERAPY DEVICEJune 2021August 2025Allow5030YesNo
17418932GAS INHALATION DEVICE WITH CONSTANT CONCENTRATION OF GAS ENTERING RESPIRATORY TRACT AND WITHOUT RESPIRATORY RESISTANCEJune 2021February 2026Allow5630YesNo
17359329Personal Protective MaskJune 2021May 2025Abandon4611NoNo
17354049ONE-TOUCH VENTILATION MODEJune 2021February 2025Abandon4401NoNo
17352735DUAL GASKET FOR USE WITH FACE MASKSJune 2021April 2025Abandon4620NoNo
17343628CABLE-ACTUATED, KINETICALLY-BALANCED, PARALLEL TORQUE TRANSFER EXOSKELETON JOINT ACTUATOR WITH OR WITHOUT STRAIN SENSINGJune 2021December 2025Allow5530NoNo
17325158Decontamination Device for Inhaled and Exhaled Ventilator GasesMay 2021October 2024Abandon4010NoNo
17323763ISOLATION DEVICES TO REDUCE CONTAMINATION DURING IMAGING OF PATIENTSMay 2021February 2026Abandon5731NoNo
17323508Transparent Protective Face MaskMay 2021November 2024Abandon4201NoNo
17293820DEVICE FOR UPPER LIMB REHABILITATIONMay 2021October 2024Abandon4210NoNo
17290190WEARABLE SYSTEM FOR CLEANING AIRApril 2021August 2025Abandon5140NoNo
17288040VENTILATION THERAPY APPARATUS AND CONTROL METHODApril 2021January 2026Abandon5740YesNo
17288033VENTILATION THERAPY APPARATUS AND CONTROL METHOD FOR SAMEApril 2021March 2026Abandon5940YesNo
17287878WATER TANK MOUNTING STRUCTURE FOR VENTILATION TREATMENT APPARATUS AND VENTILATION TREATMENT APPARATUSApril 2021September 2024Allow4110YesNo
17237247Filter Cartridge with Turbulence Generating FeaturesApril 2021May 2024Allow3710NoNo
17235943Head-mounted Air PurifierApril 2021August 2024Abandon4010NoNo
17236867Cartridge for Respiration DeviceApril 2021September 2024Abandon4110NoNo
17222476LOCATION GUIDANCE-ENABLED CPR ASSIST DEVICEApril 2021November 2024Abandon4310NoNo
17215719PROTECTIVE MASKMarch 2021June 2025Abandon5021NoNo
17216432COLD STERILIZABLE PROTECTIVE MASKMarch 2021October 2025Allow5430YesNo
17215755FACE COVERINGMarch 2021December 2024Abandon4420YesNo
17214831INHALATORMarch 2021July 2024Abandon3901NoNo
17212054POWERED AIR PURIFYING RESPIRATOR AND METHOD OF OPERATIONMarch 2021June 2024Abandon3901NoNo
17279169RESPIRATORY INFORMATION ACQUISITION DEVICEMarch 2021May 2025Abandon5020NoNo
17209215Face Mask Providing Filtered Intake and Exhaust AirMarch 2021August 2024Abandon4010NoNo
17206464TWO-WAY PROTECTIVE RESPIRATOR SYSTEM WITH POSITIVE AIR FLOW AGAINST AIRBORNE CONTAMINANT PARTICLES AND VAPOR COMPONENTSMarch 2021November 2023Allow3200YesNo
17277780SYSTEMS, DEVICES AND METHODS FOR MODULATING A RESPIRATORY DRIVE OF A PATIENTMarch 2021May 2025Allow5021YesNo
17277785ENDOTRACHEAL TUBE STABILIZERMarch 2021March 2025Allow4820YesNo
17204115GAS EVACUATING PATIENT INTERFACEMarch 2021September 2024Abandon4220NoNo
17275214A MULTI-USERS MEDICAL CANNABIS DISPENSERMarch 2021August 2024Allow4220YesNo
17194080COMPRESSION SLEEVE WITH VIBRATING UNITSMarch 2021May 2024Abandon3910NoNo
17173994Sanitary Safety Mask AssemblyFebruary 2021October 2024Abandon4420NoNo
17170974FACE MASKFebruary 2021April 2024Abandon3910NoNo
17163226VIBRATORY INFRARED OLIGODYNAMIC APPARATUS AND MUSCULOSKELETAL PAIN TREATMENT METHOD USING SAMEJanuary 2021December 2025Abandon5841YesNo
17264374LACTATION AID AND BREAST TISSUE THERAPEUTIC DEVICEJanuary 2021November 2025Allow5740YesNo
17149720FACE MASK WITH RESEALABLE OPENINGJanuary 2021April 2024Abandon3910NoNo
17257916GAS CONTROL DEVICE FOR A VENTILATORJanuary 2021February 2026Allow6020YesYes
17123105FULL-COVER TYPE PORTABLE AIR PURIFIERDecember 2020April 2024Abandon4010NoNo
16972780APPARATUS FOR USE IN DELIVERING RESPIRATORY DRUGSDecember 2020November 2024Abandon4820YesNo
17097999FRAME FOR A MEDICAL FACE MASKNovember 2020March 2024Abandon4010NoNo
17089001Interchangeable Filter Facemask ApparatusNovember 2020November 2024Abandon4820NoNo
17069813ORAL IRRIGATOR WITH WATER VOLUME STEPLESS ADJUSTMENT DEVICEOctober 2020October 2025Abandon6040YesNo
16984759Fresh Air/Oxygen Portable Breathing Device With or Without Aromas and Methods of UseAugust 2020November 2023Abandon4011NoNo
16964990DEVICE FOR REDUCTION OF VIBRATIONSJuly 2020July 2024Allow4810YesNo
16860814SYSTEM AND METHODS FOR PULMONARY EXPANSION THERAPY (PXT)April 2020April 2024Abandon4820NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner DAHER, KIRA B.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
1
Examiner Affirmed
1
(100.0%)
Examiner Reversed
0
(0.0%)
Reversal Percentile
20.6%
Lower than average

What This Means

With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.

Strategic Value of Filing an Appeal

Total Appeal Filings
2
Allowed After Appeal Filing
1
(50.0%)
Not Allowed After Appeal Filing
1
(50.0%)
Filing Benefit Percentile
84.1%
Higher than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 50.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the top 25% across the USPTO, indicating that filing appeals is particularly effective here. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal is strategically valuable. The act of filing often prompts favorable reconsideration during the mandatory appeal conference.

Examiner DAHER, KIRA B - Prosecution Strategy Guide

Executive Summary

Examiner DAHER, KIRA B works in Art Unit 3785 and has examined 65 patent applications in our dataset. With an allowance rate of 33.8%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 44 months.

Allowance Patterns

Examiner DAHER, KIRA B's allowance rate of 33.8% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by DAHER, KIRA B receive 1.66 office actions before reaching final disposition. This places the examiner in the 33% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by DAHER, KIRA B is 44 months. This places the examiner in the 15% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +55.5% benefit to allowance rate for applications examined by DAHER, KIRA B. This interview benefit is in the 95% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 30.6% of applications are subsequently allowed. This success rate is in the 61% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 16.7% of cases where such amendments are filed. This entry rate is in the 19% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 66.7% of appeals filed. This is in the 52% percentile among all examiners. Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 120.0% are granted (fully or in part). This grant rate is in the 95% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 47% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 49% percentile). This examiner issues Quayle actions less often than average. Allowances may come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.